Headache: The Journal of Head and Face Pain

In This Issue
pp. 1401-1401(1)

Expanding Access to Triptans: Assessment of Clinical Outcome
pp. 1402-1413(12)
Authors: Cady, Roger K.; Goldstein, Jerome; Silberstein, Stephen; Juhász, Márta; Ramsey, Karen; Rodgers, Anthony; Hustad, Carolyn M.; Ho, Tony

The Safety of Sumatriptan and Naratriptan in Pregnancy: What Have We Learned?
pp. 1414-1422(9)
Authors: Cunnington, Marianne; Ephross, Sara; Churchill, Paige

Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism
pp. 1423-1434(12)
Authors: Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih M.

Needle-Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use
pp. 1435-1444(10)
Authors: Brandes, Jan Lewis; Cady, Roger K.; Freitag, Fred G.; Smith, Timothy R.; Chandler, Patricia; Fox, Anthony W.; Linn, Lawrence; Farr, Stephen J.

Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine
pp. 1445-1453(9)
Authors: Dilone, Enrique; Bergstrom, David; Cabana, Bernard; Nedumpara, Mercy; Fox, Anthony W.

Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study
pp. 1454-1465(12)
Authors: Nelles, Gereon; Delbrück, Anette; Schulze, Lutz; Kademann, Barbara; Bornhoevd, Karin; Schäfer, Susanne; Schäuble, Barbara

A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX^®) and Topiramate (TOPAMAX^®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
pp. 1466-1478(13)
Authors: Mathew, Ninan T.; Jaffri, Sayyed Farhan A.

Occipital Nerve Blocks: Effect of Symptomatic Medication: Overuse and Headache Type on Failure Rate
pp. 1479-1485(7)
Authors: Tobin, Joshua A.; Flitman, Stephen S.

Serotonin Effects on Sleep and Emotional Disorders in Adolescent Migraine
pp. 1486-1492(7)
Authors: Pakalnis, Ann; Splaingard, Mark; Splaingard, Deborah; Kring, Donna; Colvin, Andrew

A Twin Study of Depression and Migraine: Evidence for a Shared Genetic Vulnerability
pp. 1493-1502(10)
Authors: Schur, Ellen A.; Noonan, Carolyn; Buchwald, Dedra; Goldberg, Jack; Afari, Niloofar

Prevalence and Incidence of Headache in Adolescent Finnish Twins
pp. 1503-1512(10)
Authors: Virtanen, Ruut; Aromaa, Minna; Koskenvuo, Markku; Sillanpää, Matti; Rose, Richard J.; Metsähonkala, Liisa; Helenius, Hans; Anttila, Pirjo; Kaprio, Jaakko

Frequency of Chronic Headaches in Japanese Patients With Multiple Sclerosis: With Special Reference to Opticospinal and Common Forms of Multiple Sclerosis
pp. 1513-1520(8)
Authors: Doi, Hikaru; Matsushita, Takuya; Isobe, Noriko; Ishizu, Takaaki; Ohyagi, Yasumasa; Kira, Jun-ichi

Occipital Nerve Blocks: When and What to Inject?
pp. 1521-1533(13)
Authors: Tobin, Joshua; Flitman, Stephen

Images From Headache: Intracranial Hypotension Complicating Marfan's Syndrome
pp. 1534-1535(2)
Authors: Decontee, Jimmeh; Joel, Cure; John, Rothrock

Expert Opinion: What Causes Migraine: Which Physician Explanation Do Patients Prefer and Understand?
pp. 1536-1540(5)
Authors: Evans, Randolph W.; Evans, Rochelle E.

Middle Meningeal Artery Dilatation in Migraine
pp. 1541-1543(3)
Author: Shevel, Elliot

Higher Serum Levels of s100b and Lower Serum Levels of NSE in Migraineurs
pp. 1544-1544(1)

Higher Serum Levels of s100b and Lower Serum Levels of NSE in Migraineurs: A Response
pp. 1544-1545(2)

Generic Topiramate for Migraine Prevention: Is Bioequivalence the Same as Therapeutic Equivalence?
pp. 1545-1546(2)

Association of Hemicrania Continua and Temporomandibular Dysfunction: The Role of Each Team Player
pp. 1547-1548(2)

A Comment on Remarks Regarding Schoonman et al Migraine Headache Is Not Associated With Cerebral or Meningeal Vasodilatation - A 3T Magnetic Resonance Angiography Study
pp. 1548-1549(2)

Retropharyngeal Tendonitis
pp. 1549-1550(2)

Resident and Fellow Section
pp. 1551-1554(4)
Author: Levin, Morris

Headache Reviewers
pp. 1555-1558(4)

Botox Haiku / The Challenging Patient
pp. 1559-1559(1)